Signature Equity Partners’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Other funds holding BIIB
Signature Equity Partners's BIIB Position: Q2 2026 in Review
Signature Equity Partners increased its Biogen (BIIB) stake by 25% in Q2 2026, buying an estimated $1.72K and bringing the position to 45 shares worth $9.72K. The position accounts for ﹤0.01% of the portfolio, ranked #819.
Signature Equity Partners first reported a position in BIIB in Q4 2025 and has held it in 3 quarters since. 1,041 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.
- Signature Equity Partners held 45 shares of Biogen worth $9.72K as of Q2 2026.
- Signature Equity Partners bought 9 Biogen shares in Q2 2026, an estimated $1.72K.
- Biogen made up ﹤0.01% of Signature Equity Partners's portfolio in Q2 2026, its #819 holding.
- Signature Equity Partners first reported a position in Biogen in Q4 2025 and has held it in 3 quarters since.
- 1,041 funds tracked by Wall St. Rank held Biogen as of Q2 2026.
Based on Signature Equity Partners's 13F filing for Q2 2026, filed 30 Jul 2026.